Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05566704 · ClinicalTrials.gov registry record
Retrospective Modulus ALIF Study
A clinical trial of Degenerative Disc Disease and Spondylolisthesis, sponsored by NuVasive.
- Completed
- Registry status
- 123
- Enrollment target
- 5
- Study locations
NCT05566704: Completed study of Degenerative Disc Disease and Spondylolisthesis, sponsored by NuVasive.
NCT05566704 is a study of Degenerative Disc Disease and Spondylolisthesis that has completed, run by NuVasive. The registered enrollment target is 123 participants, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (26% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05566704, a study of Degenerative Disc Disease and Spondylolisthesis, has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary objective of this study is to evaluate the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion (ALIF) as measured by reported complications, radiographic outcomes, and patient-reported outcomes.
Conditions Studied
Interventions
- DEVICE Modulus ALIF System
Study Locations (5)
California
- Hoag Orthopedics - Orange
- Girard Orthopedic Surgeons - San Diego
North Carolina
- OrthoCarolina - Charlotte
- Atlantic Brain and Spine - Wilmington
Georgia
- Georgia Spine & Neurosurgery Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2022-08-18 |
| Est. Completion | 2024-05-01 |
What the finished NCT05566704 record still lists
NCT05566704 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (26% lower).
The record links to 3 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Modulus ALIF System is the first listed.
NCT05566704 lists 5 locations in 3 states (California, North Carolina, Georgia).
Frequently Asked Questions
What is clinical trial NCT05566704 about?
NCT05566704 is a clinical study titled "Retrospective Modulus ALIF Study". The primary objective of this study is to evaluate the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion (ALIF) as measured by reported complications, radiographic outcomes, and patient-reported outcomes.
What is the current status of trial NCT05566704?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2022-08-18. Estimated completion is 2024-05-01.
What conditions does trial NCT05566704 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Spondylolisthesis, Stenosis.
What interventions are being tested in trial NCT05566704?
The interventions under investigation include: Modulus ALIF System (DEVICE).
Who is sponsoring clinical trial NCT05566704?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05566704 being conducted?
This trial has 5 study locations across California, Georgia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05566704's enrollment target sits among peer trials
123 18th of 42 higher than 25 of 42 other Degenerative Disc Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI